COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

31,250 Articles (22,733 medRxiv, 8,517 bioRxiv)

Most recent first Previous |  Page 437: Articles 4361-4370  | Next

Establishment of a screening platform based on human coronavirus OC43 for the identification of microbial natural products with antiviral activity
Martinez-Arribas, B., Annang, F. B., Diaz-Gonzalez, R., Perez-Moreno, G., Martin, J., Mackenzie, T. A., Castillo, F., Reyes, F., Genilloud, O., Ruiz-Perez, L. M., Vicente, F., Ramos, M. C., Gonzalez-Pacanowska, D.
10.1101/2023.04.20.537680 — Posted: 2023-04-21
Outcomes of non-hospitalized isolation service during COVID-19 pandemic
Tansawet, A.
10.1101/2023.04.19.23288791 — Posted: 2023-04-20
The Effect of COVID-19 Public Health Measures On Mental Health in California
Asgari Mehrabadi, M., Nurmi, E., Borelli, J., Lambert, N., Rahmani, A. M., Downs, C. A., Pinto, M. D.
10.1101/2023.04.17.23288661 — Posted: 2023-04-20
An estimate of pediatric lives saved due to non-pharmacologic interventions during the early COVID-19 pandemic
Faust, J. S., Renton, B., Du, C., Chen, A. J., Li, S.-X., Lin, Z., Krumholz, H. M.
10.1101/2023.04.18.23288763 — Posted: 2023-04-20
Mortality among persons with HIV in the United States during the COVID-19 pandemic: a population-level analysis
Viguerie, A., Song, R., Bosh, K., Lyles, C. M., Farnham, P. G.
10.1101/2023.04.19.23288817 — Posted: 2023-04-20
Preliminary clinical characteristics of Pediatric Covid-19 cases during the ongoing Omicron XBB.1.16 driven surge in a north Indian city
Vashishtha, V. M., Kumar, P.
10.1101/2023.04.18.23288715 — Posted: 2023-04-20
COVID-19 testing avoidance among patients with cardiovascular disease
Matsumura, K., Tabuchi, T., Yagi, E., Ijichi, T., Hasegawa, M., Yamada, N., Funauchi, Y., Kakehi, K., Kawamura, T., Nakazawa, G.
10.1101/2023.04.17.23288710 — Posted: 2023-04-20
COVID-19 illness severity and 2-year prevalence of physical symptoms: an observational study in Iceland, Sweden, Norway and Denmark
Shen, Q., Joyce, E. E., Ebrahimi, O. V., Didriksen, M., Lovik, A., Savarsdottir, K. S., Magnusdottir, I., Mikkelsen, D. H., Unnarsdottir, A. B., Hauksdottir, A., Hoffart, A., Kahler, A., Thordardottir, E. B., Eythorsson, E., Frans, E. M., Tomasson, G., Ask, H., Hardardottir, H., Jakobsdottir, J., Lehto, K., Lu, L., Andreassen, O., Sullivan, P., Palsson, R., Erikstrup, C., Ostrowski, S. R., Werge, T., Aspelund, T., Pedersen, O. B. V., Johnson, S. U., Fang, F., Valdimarsdottir, U.
10.1101/2023.04.18.23288720 — Posted: 2023-04-20
Sialoglycan binding triggers spike opening in a human coronavirus
Pronker, M. F., Creutznacher, R., Drulyte, I., Hulswit, R. J. G., Li, Z., van Kuppeveld, F. J. M., Snijder, J., Lang, Y., Bosch, B.-J., Boons, G.-J., Frank, M., de Groot, R. J., Hurdiss, D. L.
10.1101/2023.04.20.536837 — Posted: 2023-04-20
Mobilisation and analyses of publicly available SARS-CoV-2 data for pandemic responses
Rahman, N., O'Cathail, C., Zyoud, A., Sokolov, A., Oude Munnink, B., Grüning, B. A., Cummins, C., Amid, C., Nieuwenhuijse, D. F., Visontai, D., Yuan, D. Y., Gupta, D., Prasad, D., Gulyas, G. M., Rinck, G., McKinnon, J., Knaggs, J., Skiby, J. E., Steger, J., Szarvas, J., Gueye, K., Papp, K., Hoek, M., Kumar, M., Ventouratou, M. A., Bouquieaux, M.-C., Koliba, M., Mansurova, M., Haseeb, M., Worp, N., Harrison, P. W., Leinonen, R., Thorne, R., Selvakumar, S., Hunt, S., Venkataraman, S., Jayathilaka, S., Cezard, T., Maier, W., Waheed, Z., Iqbal, Z., Aarestrup, F. M., Csabai, I., Koopmans, M., Burdett, T., Cochrane, G.
10.1101/2023.04.19.537514 — Posted: 2023-04-20

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).